Clinical Trials Browser

Interventional × Margins of Excision × Genitourinary × Clear all

Margins of Excision, Adenocarcinoma, Prostatic Neoplasms

NCT07517198 2026-04-08

Dose Determining Study of EXS74539 (REC-4539) in Participants With Select Solid Tumors

BreastGastrointestinalGenitourinaryGynecologicHead & NeckThoracic

Margins of Excision, Squamous Cell Carcinoma of Head and Neck, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Liver Neoplasms, Ovarian Neoplasms, Prostatic Neoplasms, Stomach Neoplasms, Small Cell Lung Carcinoma, Triple Negative Breast Neoplasms

NCT07141121 2025-10-07

IMARHGIN

Phase NA Recruiting

78 enrolled

Genitourinary

Margins of Excision, Prostatic Neoplasms

NCT06398470 2025-01-10

Study to Evaluate a New Method to Detect Residual Tumours During Surgery for Prostate Cancer Using Confocal Microscopy

Phase 1/2 Completed

21 enrolled

Genitourinary

Margins of Excision, Prostatic Neoplasms

NCT04129606 2019-10-17

TURBT-BP

Phase NA Unknown

300 enrolled

Genitourinary

Margins of Excision, Urinary Bladder Neoplasms, Neoplasm Seeding, Recurrence, Wounds and Injuries

NCT01460134 2018-01-31

A Study of CDX-1127 (Varlilumab) in Patients With Select Solid Tumor Types or Hematologic Cancers

Phase 1 Completed

90 enrolled

DermatologicGenitourinaryGynecologicLymphoidOther hematologic neoplasmThoracic

Margins of Excision, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Melanoma, Ovarian Neoplasms, Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, B-Cell, Marginal Zone, Lymphoma, Mantle-Cell

NCT01784978 2017-10-02